MIAC Release

COLLEGEVILLE, Minn. – Seven Saint John's University tennis student-athletes received 2021-22 Winter and Spring Academic All-MIAC recognition on Monday, June 27.

SJU led the MIAC with 145 male honorees during the 2021-22 academic year, followed by Gustavus Adolphus (134) and Carleton (113). The Johnnies had 86 fall honorees (cross country, football, soccer), ahead of Gustavus (80) and St. Olaf (67).

Those honored (listed alphabetically) include:

-Sophomore Ian Aadland (Brainerd, Minn.), a mathematics major with a 3.91 GPA;
-Junior Hunter Fischer (Spicer, Minn./Willmar), a biology major (pre-medicine emphasis) with a 4.0 GPA;
-Junior Peyton Fischer (Spicer, Minn./Willmar), a biology major with a 3.94 GPA;
-Junior Will Fischer (Spicer, Minn./Willmar), a computer science major with a 3.86 GPA;
-Sophomore Mason Meyer (Bloomington, Minn./Jefferson), a computer science major with a 3.57 GPA;
-Sophomore Nolan Morrey (Rochester, Minn./Lourdes), a history major with a 3.98 GPA;
-Sophomore Mark Rosen (Bloomington, Minn./Jefferson), an accounting major with a 3.71 GPA.

Student-athletes must be a sophomore, junior or senior academically with a minimum cumulative GPA of 3.50 on a 4.00 scale to qualify for Academic All-MIAC recognition. Transfers, like freshmen, must complete a full academic year to be eligible the following season. 

Athletically, student-athletes must be a member of a MIAC-sponsored, varsity team and be academically and athletically eligible. The student-athlete must have utilized a season of participation (per NCAA and MIAC definitions) and have remained on the sports roster through the conclusion of the sports season.

The Academic All-MIAC honor is the second consecutive for Hunter and Peyton Fischer. On the court, Peyton earned All-MIAC distinction in both singles and doubles play, while Hunter achieved the honor in doubles competition.

The Johnnies finished fourth in the MIAC with a 6-3 record (10-7 overall) to earn their eighth MIAC Playoff appearance in the last 10 seasons and 15th overall in 2022.